Literature DB >> 26834854

Association of SIRT1 and HMGA1 expression in non-small cell lung cancer.

Shuang-Yan Lin1, Fang Peng1.   

Abstract

The roles of Silent mating type information regulation 2 homolog 1 (SIRT1) and High mobility group A1 (HMGA1) in human diseases have been extensively studied separately; however, to the best of our knowledge, the current study is the first to report on their interrelationship in lung cancer. The association of SIRT1 and HMGA1 in non-small cell lung cancer (NSCLC) was investigated by evaluating their expression and prognostic significance in 260 patients with NSCLC using immunohistochemistry. SIRT1 and HMGA1 expression were found to be significantly correlated with each other (P<0.001), and both were significantly associated with clinicopathological parameters, including histological type and degree of differentiation. In squamous cell carcinoma (SCC), SIRT1+ specimens were significantly associated with shorter overall survival (OS) time (P=0.019). However, in patients with adenocarcinoma (AD), no association was identified between SIRT1 and OS. In addition, HMGA1+ specimens were significantly associated with poor differentiation (P=0.028), and were more frequent in SCC than AD (P=0.015). However, HMGA1 was not associated with OS on univariate Cox regression analysis or Kaplan-Meier analysis (both P>0.05). SIRT1/HMGA1 coexpression was significantly associated with male gender (P=0.016), and moderately and poorly differentiated histological grade (P=0.025). The findings indicate that SIRT1 and HMGA1 may have significant effects during tumor progression in NSCLC, particularly in patients with SCC, and are potentially useful as prognostic indicators for patients with NSCLC.

Entities:  

Keywords:  HMGA1; SIRT1; adenocarcinoma; non-small cell lung cancer; squamous cell carcinoma

Year:  2015        PMID: 26834854      PMCID: PMC4726940          DOI: 10.3892/ol.2015.3914

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  53 in total

1.  High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.

Authors:  Francesco Esposito; Mara Tornincasa; Paolo Chieffi; Ivana De Martino; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.

Authors:  Barrie Peck; Chun-Yuan Chen; Ka-Kei Ho; Paolo Di Fruscia; Stephen S Myatt; R Charles Coombes; Matthew J Fuchter; Chwan-Deng Hsiao; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

3.  High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.

Authors:  G M Pierantoni; C Rinaldo; F Esposito; M Mottolese; S Soddu; A Fusco
Journal:  Cell Death Differ       Date:  2005-12-09       Impact factor: 15.828

4.  Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y.

Authors:  K R Johnson; D A Lehn; R Reeves
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

5.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

6.  Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.

Authors:  Sang Jae Noh; Hyun Ah Baek; Ho Sung Park; Kyu Yun Jang; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Min Ho Kim; Ju Hyung Lee; Myoung Ja Chung
Journal:  Pathol Res Pract       Date:  2013-04-15       Impact factor: 3.250

7.  Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

Authors:  Y Tamimi; H G van der Poel; M M Denyn; R Umbas; H F Karthaus; F M Debruyne; J A Schalken
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

8.  Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

Authors:  Ruo-Chia Tseng; Chin-Chu Lee; Han-Shui Hsu; Ching Tzao; Yi-Ching Wang
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

Review 9.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

10.  Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.

Authors:  D Dixit; V Sharma; S Ghosh; V S Mehta; E Sen
Journal:  Cell Death Dis       Date:  2012-02-09       Impact factor: 8.469

View more
  14 in total

1.  Sirt1 protects from K-Ras-driven lung carcinogenesis.

Authors:  Luis Filipe Costa-Machado; Roberto Martín-Hernández; Miguel Ángel Sanchez-Luengo; Katharina Hess; Claudia Vales-Villamarin; Marta Barradas; Cian Lynch; Daniel de la Nava; Alberto Diaz-Ruiz; Rafael de Cabo; Marta Cañamero; Lola Martinez; Marta Sanchez-Carbayo; Daniel Herranz; Manuel Serrano; Pablo J Fernandez-Marcos
Journal:  EMBO Rep       Date:  2018-07-18       Impact factor: 8.807

2.  HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.

Authors:  Lias Saed; Ewa Balcerczak; Mariusz Łochowski; Ewa Olechnowicz; Aleksandra Sałagacka-Kubiak
Journal:  Mol Genet Genomics       Date:  2022-08-10       Impact factor: 2.980

3.  Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis.

Authors:  Lias Saed; Agnieszka Jeleń; Marek Mirowski; Aleksandra Sałagacka-Kubiak
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

4.  Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.

Authors:  Yue-Ya Liang; Jia-Cheng Huang; Rui-Xue Tang; Wen-Jie Chen; Peng Chen; Wei-Luan Cen; Ke Shi; Li Gao; Xiang Gao; An-Gui Liu; Xiao-Tong Peng; Gang Chen; Su-Ning Huang; Ye-Ying Fang; Yong-Yao Gu
Journal:  World J Surg Oncol       Date:  2018-02-02       Impact factor: 2.754

5.  Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis.

Authors:  Yifei Chen; Tao Wang; Wei Wang; Jiahao Hu; Ruiting Li; Shaojun He; Jiong Yang
Journal:  Oncotarget       Date:  2017-07-12

6.  SIRT1 gene polymorphisms and risk of lung cancer.

Authors:  Yanbo Lv; Shuangyan Lin; Fang Peng
Journal:  Cancer Manag Res       Date:  2017-09-04       Impact factor: 3.989

7.  Associations of sirtuins with clinicopathological parameters and prognosis in non-small cell lung cancer.

Authors:  Jian Gong; Huiyan Wang; Wenwen Lou; Guiye Wang; Hongqun Tao; Huaikai Wen; Yu Liu; Qipeng Xie
Journal:  Cancer Manag Res       Date:  2018-09-10       Impact factor: 3.989

8.  Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.

Authors:  Wen-Jie Chen; Rui-Xue Tang; Rong-Quan He; Dong-Yao Li; Liang Liang; Jiang-Hui Zeng; Xiao-Hua Hu; Jie Ma; Shi-Kang Li; Gang Chen
Journal:  Oncotarget       Date:  2017-05-22

9.  Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling

Authors:  Wenxia Jiang; Likun Hou; Juan Wei; Yifeng Du; Yan Zhao; Xue Deng; Xiangdong Lin
Journal:  Balkan Med J       Date:  2020-04-09       Impact factor: 2.021

10.  MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells.

Authors:  Yu Ma; Xuena Li; Song Chen; Bulin Du; Yaming Li
Journal:  Cancer Manag Res       Date:  2019-01-10       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.